Rebecca A. Redman, M.D.

• Associate Professor of Medicine
• Associate Director of Clinical Trials, UofL Health - Brown Cancer Center
• George A. Bush Jr. Professorship in Clinical Trials Cancer Research

UofL Health - Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments

Featured Publications

• Khanal S, Strickley JD, Ha T, Demehri S, Ghim SJ, Jenson AB, Redman RA, Joh JJ. Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma. Exp Mol Pathol. 2020 Dec;117:104549. doi: 10.1016/j.yexmp.2020.104549. Epub 2020 Sep 30. PMID: 33007298.
• Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R. Correction to: Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Med Oncol. 2019 Nov 1;36(12):100. doi: 10.1007/s12032-019-1319-4. Erratum for: Med Oncol. 2019 Sep 16;36(10):90. PMID: 31673861.
• Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R. Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Med Oncol. 2019 Sep 16;36(10):90. doi: 10.1007/s12032-019-1315-8. Erratum in: Med Oncol. 2019 Nov 1;36(12):100. PMID: 31529163.
• Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study. Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;: PMID: 31047803.
• May ME Jr, Cash ED, Silverman CL, Redman RA, Perez CA, Wilson LD, Tennant PA, Bumpous JM, Dunlap NE. Prognostic factors and selection criteria in the retreatment of head and neck cancers. Oral Oncol. 2019 Jan;88:85-90. doi: 10.1016/j.oraloncology.2018.11.024. Epub 2018 Nov 22. PMID: 30616802.
• Khanal S, Shumway BS, Zahin M, Redman RA, Strickley JD, Trainor PJ, Rai SN, Ghim SJ, Jenson AB, Joh J. Viral DNA integration and methylation of human papillomavirus type 16 in high-grade oral epithelial dysplasia and head and neck squamous cell carcinoma. Oncotarget. 2018 Jul 13;9(54):30419-30433. doi: 10.18632/oncotarget.25754. PMID: 30100997; PMCID: PMC6084396.
• Amsbaugh MJ, Yusuf M, Gaskins J, Silverman C, Potts K, Bumpous J, Redman R, Perez C, Dunlap N. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation. Am J Otolaryngol. 2017 Sep-Oct;38(5):588-592. doi: 10.1016/j.amjoto.2017.06.006. Epub 2017 Jun 14. PMID: 28633765.
• Perez CA, Wu X, Amsbaugh MJ, Gosain R, Claudino WM, Yusuf M, Roberts T, Jain D, Jenson A, Khanal S, Silverman CI, Tennant P, Bumpous JM, Dunlap NE, Rai SN, Redman RA. High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck. Oral Oncol. 2017 Apr;67:24-28. doi: 10.1016/j.oraloncology.2017.01.010. Epub 2017 Feb 3. PMID: 28351577.
• Amsbaugh MJ, Yusuf M, Cash E, Silverman C, Wilson E, Bumpous J, Potts K, Perez C, Bert R, Redman R, Dunlap N. Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):349-353. doi: 10.1016/j.ijrobp.2016.06.2450. Epub 2016 Jun 25. PMID: 27598805.
• Amsbaugh MJ, Yusuf M, Silverman C, Bumpous J, Perez CA, Potts K, Tennant P, Redman R, Dunlap N. Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration. Radiat Oncol J. 2016 Sep;34(3):209-215. doi: 10.3857/roj.2016.01739. Epub 2016 Sep 5. PMID: 27592515; PMCID: PMC5066443.